Updated: March 15, 2026
Vyndamax Drug Interactions: What to Avoid and What to Tell Your Doctor
Author
Peter Daggett

Summarize with AI
Vyndamax inhibits a protein called BCRP, which can increase blood levels of 33+ other medications. Here's what to tell your doctor and which drug interactions matter most.
Vyndamax (tafamidis) has a favorable overall safety profile — but it does interact with a meaningful number of other medications through a specific biochemical mechanism. Understanding which drugs are affected and why helps patients and caregivers have informed conversations with their cardiologist and pharmacist.
The Core Interaction Mechanism: BCRP Inhibition
Vyndamax inhibits a transport protein called BCRP (Breast Cancer Resistance Protein — also known as ABCG2). BCRP is a drug transporter found in the gut, liver, and kidneys. It acts like a pump that removes certain medications from cells and blood, thereby limiting how much of the drug accumulates in your body.
When Vyndamax inhibits BCRP, the pump works less efficiently. This means that drugs normally cleared by BCRP (called BCRP substrates) may build up to higher levels in your bloodstream than expected. Higher drug levels can increase both the therapeutic effects AND the side effects of those medications.
Major Interaction — Avoid If Possible
There is one major-severity interaction with Vyndamax that should be avoided if possible:
- Alpelisib (Piqray): A cancer medication used for HR+/HER2- breast cancer. Coadministration with Vyndamax can significantly increase alpelisib blood levels, raising the risk of severe toxicities including hyperglycemia, skin reactions, and diarrhea. Avoid combining these medications when possible. If needed, monitor closely for alpelisib toxicities.
- Ozanimod (Zeposia): Used for multiple sclerosis and ulcerative colitis. Vyndamax can increase exposure of ozanimod's active metabolites, raising risk of adverse effects including cardiovascular reactions. Avoid coadministration.
Moderate Interactions — Monitor Closely
The following medications are BCRP substrates and may have elevated blood levels when taken with Vyndamax. Dose adjustments may be needed — discuss with your doctor or pharmacist:
- Methotrexate (Trexall): Used for rheumatoid arthritis and certain cancers. Vyndamax may increase methotrexate levels — monitor for toxicity (mouth sores, blood count changes, liver effects).
- Rosuvastatin (Crestor): A common cholesterol medication. Vyndamax may increase rosuvastatin levels; monitor for muscle pain or weakness (myopathy). Dose reduction may be appropriate.
- Imatinib (Gleevec): A cancer medication. Vyndamax may increase imatinib exposure.
- Atorvastatin (Lipitor): Another statin cholesterol medication. Monitor for muscle side effects.
- Fluvastatin (Lescol): Same monitoring applies as other statins.
- Glyburide: A diabetes medication (sulfonylurea). Vyndamax may increase glyburide levels, potentially raising risk of hypoglycemia (low blood sugar).
- Pantoprazole (Protonix): A proton pump inhibitor (PPI) for acid reflux. Monitor if taking high doses.
- Daunorubicin / Doxorubicin: Cancer chemotherapy agents. Increased exposure could heighten toxicity.
No Known Food or Drink Interactions
There are no known interactions between Vyndamax and food or drinks. Vyndamax can be taken with or without food. The effect of alcohol on Vyndamax is not well-studied, but there is no specific recommendation to avoid alcohol at moderate levels.
What to Tell Your Doctor and Pharmacist
Before starting Vyndamax, give your cardiologist and pharmacist a complete list of all your current medications, including:
- All prescription medications
- Over-the-counter medications (NSAIDs, acid reducers, antihistamines)
- Vitamins and supplements
- Herbal products
Many ATTR-CM patients are older adults who take multiple medications for heart failure (diuretics, beta-blockers, ACE inhibitors), diabetes, high cholesterol, and other conditions. A medication review by your pharmacist can identify any potential BCRP-related interactions before they become a problem.
Pregnancy and Hormonal Medications
Vyndamax may cause fetal harm based on animal studies. Do not take Vyndamax during pregnancy. There are no known interactions with hormonal contraceptives specifically, but women of reproductive potential should discuss contraception with their doctor. For more on Vyndamax safety, see our full guide to Vyndamax side effects.
How to Stay Safe
- Conduct a medication review with your pharmacist when starting Vyndamax
- If you take statins (rosuvastatin, atorvastatin, fluvastatin), ask your cardiologist about monitoring for muscle symptoms
- If you take methotrexate, ask your rheumatologist or oncologist to review the interaction with your cardiologist
- Use one pharmacy for all prescriptions so your pharmacist can check for interactions automatically
Once you've confirmed your medication safety, medfinder can help you locate the specialty pharmacy that can fill your Vyndamax prescription quickly.
Frequently Asked Questions
Yes. Vyndamax inhibits BCRP (breast cancer resistance protein), which can increase blood levels of rosuvastatin (Crestor) and other statins like atorvastatin (Lipitor) and fluvastatin (Lescol). If you take one of these statins, your doctor may monitor you for muscle pain (myopathy) or consider adjusting the statin dose.
Use caution. Vyndamax inhibits BCRP, which may increase methotrexate levels in the body. Higher methotrexate levels can increase the risk of toxicity, including mouth sores, blood count changes, and liver effects. If you take methotrexate, inform both your rheumatologist/oncologist and cardiologist about the potential interaction so they can monitor appropriately.
No known food interactions with Vyndamax. It can be taken with or without food. The effect of alcohol is not specifically studied, but there is no recommendation to avoid alcohol at moderate levels. Alcohol may worsen heart failure symptoms generally, so patients with ATTR-CM should discuss alcohol use with their cardiologist.
Vyndamax has 33 known drug interactions: 1 major (avoid if possible: alpelisib), 31 moderate (monitor closely, including methotrexate, rosuvastatin, imatinib, atorvastatin, glyburide, pantoprazole, and others), and 1 minor. All interactions are mediated through BCRP inhibition.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Vyndamax also looked for:
More about Vyndamax
36,651 have already found their meds with Medfinder.
Start your search today.





